Cancer and Clinical proteomics

Proteomics has emerged as a promising field in the post-genomic era. Notwithstanding the great advances provided by gene expression analysis in cancer, the lack of a correlation between gene expression and protein levels has highlighted the need for a proteomic focus on cancer. Although the increasing knowledge regarding cancer biology, a reliable marker to improve diagnosis, prognosis and treatment for cancer patients is not a reality at present. In this review, we address the main considerations regarding proteomics-based studies and their clinical applications on cancer research, highlighting some considerations related to strengths and limitations of proteomics-based studies and its application to clinical practice.

  • Track 1-1 expression proteomics
  • Track 2-2 Structural Proteomics
  • Track 3-3 Bioinformatics technologies
  • Track 4-4 Proteomics technologies
  • Track 5-5 Protein Microarray
  • Track 6-6 Biomarkers
  • Track 7-7 Pharmaceutical
  • Track 8-8 drug discovery

Related Conference of Biochemistry